Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: The Jackson Heart Study

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Bidulescu, Aurelian ^a   Liu, Jiankang ^b   Hickson, DeMarc A ^b,d   Hairston, Kristen G ^c   Fox, Ervin R ^b   Arnett, Donna K ^e   Sumner, Anne E ^f   Taylor, Herman A ^b,d   Gibbons, Gary H ^g  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JACKSON STATE UNIVERSITY   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSITY; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CONE-BEAM COMPUTED TOMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; MISSISSIPPI; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84874099598     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-9     Document Type: Article

References (50)

1. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257(1):79-83. 10.1006/bbrc.1999.0255, 10092513.
2. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004, 24(1):29-33. 10.1161/01.ATV.0000099786.99623.EF, 14551151.
3. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004, 43(6):1318-1323. 10.1161/01.HYP.0000129281.03801.4b, 15123570.
4. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102(11):1296-1301. 10.1161/01.CIR.102.11.1296, 10982546.
5. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006, 16(5):141-146. 10.1016/j.tcm.2006.03.001, 2749293, 16781946.
6. Araneta MR, Barrett-Connor E. Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring) 2007, 15(10):2454-2462.
7. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005, 54(9):2772-2778. 10.2337/diabetes.54.9.2772, 16123368.
8. Considine RV, Premkumar A, Reynolds JC, Sebring NG, Ricks M, Sumner AE. Adiponectin and leptin in African Americans. Obesity (Silver Spring) 2008, 16(2):428-434.
9. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 2007, 116(1):39-48. 10.1161/CIRCULATIONAHA.106.675355, 17576866.
10. Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, Schwartz AV, Kritchevsky S, Newman AB. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003, 26(2):372-379. 10.2337/diacare.26.2.372, 12547865.
11. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Meigs JB, Lipinska I, Kathiresan S. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116(11):1234-1241. 10.1161/CIRCULATIONAHA.107.710509, 17709633.
12. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab 2010, 95(12):5419-5426. 10.1210/jc.2010-1378, 2999970, 20843952.
13. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot?. Diabetes Care 2009, 32(6):1068-1075. 10.2337/dc08-2280, 2681034, 19244087.
14. Taylor HA. The Jackson heart study: an overview. Ethn Dis 2005, 15(4 Suppl 6):S6-1-3.
15. Carpenter MA, Crow R, Steffes M, Rock W, Heilbraun J, Evans G, Skelton T, Jensen R, Sarpong D. Laboratory, reading center, and coordinating center data management methods in the Jackson heart study. Am J Med Sci 2004, 328(3):131-144. 10.1097/00000441-200409000-00001, 15367870.
16. Carithers TC, Talegawkar SA, Rowser ML, Henry OR, Dubbert PM, Bogle ML, Taylor HA, Tucker KL. Validity and calibration of food frequency questionnaires used with African-American adults in the Jackson heart study. J Am Diet Assoc 2009, 109(7):1184-1193. 10.1016/j.jada.2009.04.005, 2792037, 19559135.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
18. Bidulescu A, Liu J, Musani SK, Fox ER, Samdarshi TE, Sarpong DF, Vaccarino V, Wilson PW, Arnett DK, Din-Dzietham R. Association of adiponectin with left ventricular mass in blacks: the Jackson heart study. Circ Heart Fail 2011, 4(6):747-753. 10.1161/CIRCHEARTFAILURE.110.959742, 3218236, 21840935.
19. Shand B, Elder P, Scott R, Frampton C, Willis J. Biovariability of plasma adiponectin. Clin Chem Lab Med 2006, 44(10):1264-1268.
20. Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000, 20(8):1932-1938. 10.1161/01.ATV.20.8.1932, 10938014.
21. Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (coronary artery risk development in young adults) study. Am J Clin Nutr 1999, 69(3):381-387.
22. Katzmarzyk PT, Bray GA, Greenway FL, Johnson WD, Newton RL, Ravussin E, Ryan DH, Smith SR, Bouchard C. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 2010, 91(1):7-15. 10.3945/ajcn.2009.28136, 19828714.
23. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, Park KK, Chang YC, Lee IK. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004, 63(2):135-142. 10.1016/j.diabres.2003.09.010, 14739054.
24. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and African-Americans. J Clin Endocrinol Metab 2007, 92(7):2665-2671. 10.1210/jc.2006-2614, 17426091.
25. Nakamura Y, Sekikawa A, Kadowaki T, Kadota A, Kadowaki S, Maegawa H, Kita Y, Evans RW, Edmundowicz D, Curb JD. Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP study. Obesity (Silver Spring) 2009, 17(6):1269-1273.
26. Brambilla P, Bedogni G, Moreno LA, Goran MI, Gutin B, Fox KR, Peters DM, Barbeau P, De Simone M, Pietrobelli A. Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes (Lond) 2006, 30(1):23-30.
27. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006, 91(11):4459-4466. 10.1210/jc.2006-0814, 16926254.
28. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003, 52(10):1274-1278. 10.1016/S0026-0495(03)00195-1, 14564678.
29. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887. 10.1038/nature05488, 17167477.
30. Taylor HA, Coady SA, Levy D, Walker ER, Vasan RS, Liu J, Akylbekova EL, Garrison RJ, Fox C. Relationships of BMI to cardiovascular risk factors differ by ethnicity. Obesity (Silver Spring) 2010, 18(8):1638-1645.
31. Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Bae S, Cardarelli R. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity (Silver Spring) 2008, 16(3):600-607.
32. Okosun IS, Choi ST, Boltri JM, Parish DC, Chandra KM, Dever GE, Lucas A. Trends of abdominal adiposity in white, black, and Mexican-American adults, 1998 to 2000. Obes Res 2003, 11(8):1010-1017. 10.1038/oby.2003.139, 12917507.
33. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gomez-Gerique JA, Stern MP, Haffner SM. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003, 11(12):1480-1487. 10.1038/oby.2003.198, 14694212.
34. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002, 34(11-12):616-621.
35. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004, 89(6):2563-2568. 10.1210/jc.2004-0518, 15181024.
36. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46(4):459-469.
37. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55(1):249-259. 10.2337/diabetes.55.01.06.db05-1105, 16380500.
38. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004, 14(7):492-498. 10.1016/j.annepidem.2003.10.006, 15301786.
39. Tulloch-Reid MK, Hanson RL, Sebring NG, Reynolds JC, Premkumar A, Genovese DJ, Sumner AE. Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in african americans. Obes Res 2004, 12(8):1352-1359. 10.1038/oby.2004.170, 15340119.
40. Kanaya AM, Wassel Fyr C, Vittinghoff E, Havel PJ, Cesari M, Nicklas B, Harris T, Newman AB, Satterfield S, Cummings SR. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 2006, 91(12):5044-5050. 10.1210/jc.2006-0107, 16984981.
41. Drolet R, Belanger C, Fortier M, Huot C, Mailloux J, Legare D, Tchernof A. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 2009, 17(3):424-430.
42. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432. 10.1038/372425a0, 7984236.
43. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221(2):286-289. 10.1006/bbrc.1996.0587, 8619847.
44. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91. 10.1126/science.7678183, 7678183.
45. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996, 2(7):800-803. 10.1038/nm0796-800, 8673927.
46. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001, 409(6818):307-312. 10.1038/35053000, 11201732.
47. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009, 53(4):577-584. 10.1161/HYPERTENSIONAHA.108.110320, 19237685.
48. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51(9):2734-2741. 10.2337/diabetes.51.9.2734, 12196466.
49. Shetty S, Kusminski CM, Scherer PE. Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 2009, 30(5):234-239. 10.1016/j.tips.2009.02.004, 19359049.
50. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006, 2(4):367-373. 10.2174/1573399810602040367, 18220642.